LEONTEQ SECURITIES AG (GUERNSEY BRANCH) | Market Closed - Swiss Exchange 16:20:00 14/06/2024 BST | ||
| 103.2 USD | +0.02% |
|
| Current month | +0.24% | ||
| 1 month | +0.56% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 14/06/24 | 103.2 | +0.02% |
| 13/06/24 | 103.2 | +0.05% |
| 12/06/24 | 103.2 | +0.02% |
| 11/06/24 | 103.1 | +0.01% |
| 10/06/24 | 103.1 | +0.03% |
Delayed Quote Swiss Exchange
Last update June 14, 2024 at 04:20 pm
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | LEONTEQ |
| YUELTQ | |
| ISIN | CH1300964470 |
| Date issued | 15/12/2023 |
| Strike | 572 $ |
| Maturity | 17/03/2025 (275 Days) |
| Parity | 0.57 : 1 |
| Emission price | 100 $ |
| Emission volume | N/A |
| Settlement | both |
| Currency | USD |
Technical Indicators
| Highest since issue | 106 $ |
|---|---|
| Lowest since issue | 100.5 $ |
| Spread | 8.3 $ |
| Spread % | 0.80% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
878.4
USD
Average target price
855.4
USD
Spread / Average Target
-2.63%
- Stock Market
- Certificates
- YUELTQ Certificat
